Network origin in Michael Swartzburg first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Swartzburg via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| VIVUS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| The United States Army (District of Columbia) | Sovereign | Corporate Officer/Principal | |
| IN8BIO, INC. | Biotechnology | Director/Board Member | |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Biotechnology | Sales & Marketing | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
| GILEAD SCIENCES, INC. | Biotechnology | Sales & Marketing | |
| The University of Chicago | College/University | Masters Business Admin | |
| US Military Academy | College/University | Undergraduate Degree | |
| University of Virginia | College/University | Undergraduate Degree | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Tufts University School of Medicine | College/University | Doctorate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CARGO THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
Goldman Sachs International
 Goldman Sachs International Investment Banks/BrokersFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Investment Banks/Brokers | Analyst-Equity | |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ELICIO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| Zylem Biosciences, Inc. | Biotechnology | Founder | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree | |
| Androclus Therapeutics, Inc. | Chief Executive Officer | ||
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Moscow Institute of Physics & Technology | College/University | Undergraduate Degree | |
| The University of North Carolina at Charlotte | College/University | Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| IGNYTA INC | Biotechnology | Corporate Officer/Principal | |
| ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
| TURG POIN | Pharmaceuticals: Major | Chief Executive Officer | |
Alpine Bioventures, GP, LLC
 Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ESSEC Business School | College/University | Masters Business Admin | |
| University of Hamburg | College/University | Doctorate Degree | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AROVELLA THERAPEUTICS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| Pontifícia Universidade Católica de São Paulo | College/University | Doctorate Degree | |
| Université Paris Dauphine-PSL | College/University | Undergraduate Degree | |
| CARISMA THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 42 |
| France | 3 |
| United Kingdom | 2 |
| Russia | 2 |
| Israel | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 13 |
| Finance | 4 |
| Commercial Services | 4 |
| Government | 2 |
Operational
| Director/Board Member | 54 |
| Corporate Officer/Principal | 36 |
| Independent Dir/Board Member | 18 |
| Chief Tech/Sci/R&D Officer | 17 |
| Director of Finance/CFO | 14 |
Most connected contacts
| Insiders | |
|---|---|
| Jay Venkatesan | 30 |
| Michael Weiser | 26 |
| Timothy Morris | 21 |
| Athena Countouriotis | 17 |
| Sanford J. Hillsberg | 11 |
| Igor Bilinsky | 11 |
| Jim Ziegler | 9 |
| Raymond Stapleton | 9 |
| Corinne Epperly | 8 |
| Debora Barton | 7 |
| Jean-Marc Bellemin | 6 |
| jennifer lee | 5 |
| Igor Gorbatchevsky | 4 |
| Tracy Winton | 4 |
| Friedrich Finckenstein | 3 |
- Stock Market
- Insiders
- Michael Swartzburg
- Company connections
